title: [Hemostasis during MARS therapy and hemodiafitration in patiens with acute renal-hepatic failure].
abstract: OBJECTIVE
  to study the dynamics of the haemostatic system, depending on coagulopathy type and efferent therapy method (HDF, MARS) in patiens with acute renal-hepatic failure. As a complex of intensive therapy, all the patients were trated extracorporeal techniques: HDF therapy in group I (n = 121) and MARS in group 1 (n = 62). Patients were aged from 18 to 67 years.
  
  
  CONCLUSIONS
  MARS - is an effective therapy and has effects on haemostasis system: observed recovery of platelet-vascular disorders of coagulation and haemostasis. HDF is effective in patients with coagulation type of laboratory disseminated intravascular coagulation (DIC), and was dangerous in fibrinolytic DIC type because of haemostasis status decompensation risk.
authors.forename: A F
authors.initials: AF
authors.lastname: Iampol'skiĭ
authors.forename: L F
authors.initials: LF
authors.lastname: Eremeeva
authors.forename: V V
authors.initials: VV
authors.lastname: Menshchikov
authors.forename: I B
authors.initials: IB
authors.lastname: Zabolotskikh
mesh_terms: D000293:Adolescent; D000327:Adsorption; D000328:Adult; D000368:Aged; D001778:Blood Coagulation Disorders / Q000097:blood / Q000209:etiology / Q000628:therapy*; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000209:etiology / Q000628:therapy; D005260:Female; D017583:Hemodiafiltration / Q000379:methods*; D006487:Hemostasis / Q000502:physiology*; D048550:Hepatic Insufficiency / Q000097:blood / Q000150:complications / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D051437:Renal Insufficiency / Q000097:blood / Q000150:complications / Q000628:therapy*; D016060:Sorption Detoxification / Q000379:methods; D013577:Syndrome; D016896:Treatment Outcome; D055815:Young Adult